Caroline Rufo


Merck Ventures
Gustav Mahlerplein 84 A
Toyo lto Building, 13th Floor
1082 MA Amsterdam
The Netherlands

Caroline Rufo, PhD, joined the Healthcare Team as an analyst in April 2017. Previously, Caroline was a Postdoctoral Associate at Yale University (USA) in the Department of Molecular Biophysics and Biochemistry where she performed research focusing on the influence of the Rho/ROCK signaling pathway on cancer drugs. Caroline received her PhD in Chemistry from Syracuse University (USA) and her research studying the self-assembly of small peptides to create catalysts was published in Nature Chemistry. Caroline is based in Amsterdam.

Portfolio Company

more about
Akili